Printer Friendly Version View printer-friendly version
<< Back
Array BioPharma To Report Financial Results For The First Quarter Of Fiscal 2017 On November 1, 2016

BOULDER, Colo., Oct. 25, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq:  ARRY) will report financial results for the first quarter of fiscal 2017 and hold a conference call to discuss those results on Tuesday, November 1, 2016. Ron Squarer, Chief Executive Officer, will lead the call.


Tuesday, November 1, 2016


9:00 a.m. Eastern Time


(844) 464-3927


(765) 507-2598

Pass Code:      


Webcast, including Replay and Conference Call Slides:

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Five registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca).


Tricia Haugeto                          

Array BioPharma Inc.

(303) 386-1193


Array BioPharma.

Logo -


To view the original version on PR Newswire, visit:

SOURCE Array BioPharma Inc.